#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the cervix Toxic epidermal necrolysis Cystic fibrosis respiratory infection suppression X-linked lymphoproliferative syndrome Kawasaki's disease Glomerulonephritis acute Lymphangiosarcoma Squamous cell carcinoma of head and neck Dermatomyositis T-cell lymphoma Cerebellar ataxia Meningitis meningococcal Chronic graft versus host disease in liver Endocrine ophthalmopathy B precursor type acute leukaemia More trials…

    Learn about Rare Diseases

    Angiosarcoma – Life with Disease Chronic granulomatous disease – Diagnostics Hereditary motor and sensory neuropathy – Life with Disease Usher’s syndrome Langerhans cell sarcoma Friedreich’s ataxia – Diagnostics Lymphatic malformation – Trials in Disease Inclusion body myositis Progressive multifocal leukoencephalopathy – Trials in Disease Cytokine release syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lovo-A Abacavir Folic Acid Ixazomib Fosamprenavir Calcium Cholic Acid Metolazone Seralutinib LUTETIUM LU-177 Azd0305 VELPATASVIR Tucidinostat HSP-CAR30 PEGVISOMANT Celecoxib Clobetasol Propionate SONLICROMANOL HYDROCHLORIDE Xanomeline Tartrate Lauromacrogol 400 Atezolizumab More therapies…

    Learn about Your Condition

    Rhabdoid tumour of the kidney Pseudomyxoma peritonei Bone sarcoma Prinzmetal angina Chronic coronary syndrome Giardiasis Graft infection Hodgkin's disease recurrent Liposarcoma Pulmonary sarcoidosis Desmoplastic melanoma Ichthyosis Leukocyte adhesion deficiency Diabetic foot infection Usher's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Sud Francilien

Centre Hospitalier Sud Francilien

40 Avenue Serge Dassault, Corbeil Essonnes, 91106, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Ivabradine for Heart Rate Control and Survival in Adults with Septic Shock

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Ivabradine Hydrochloride
    France

  • Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    Belgium France

  • Study on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Itacitinib
    France

  • Study of Rituximab, Prednisolone and Betamethasone in Adult Patients with First Episode of Minimal Change Nephrotic Syndrome to Prevent Disease Relapse

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Prednisolone
    • Rituximab
    France

  • Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epoetin Alfa
    France

  • Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    Investigated Drugs:
    • Oxaliplatin
    Belgium France

  • Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Dexamethasone
    • Human Normal Immunoglobulin (Iv)
    • Prednisolone
    France

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Czechia Denmark France Germany Hungary +4

  • Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neonatal hyperglycaemia
    Investigated Drugs:
    • Glibenclamide
    France
Previous Page
1 … 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!